BioMime MORPH Sirolimus Eluting Tapered Coronary Stent System
BioMime · Drug Eluting Stents
BioMime MORPH Sirolimus Eluting Tapered Coronary Stent System
| Technical Blueprint Specification | Clinical Value |
|---|---|
STENT Material | Cobalt Chromium (L605) |
Strut Thickness | 65µm (0.065mm or 0.026") |
Stent Diameter (mm) | 2.00, 2.25, 2.50, 2.,75, 3.00, 3.50, 4.00, 4.50 |
Stent Length (mm) | 8, 13, 16, 19, 24, 29, 32, 37, 40, 44, 48 |
Mean Recoil | ≤4.0% |
Mean Foreshortening | ≤1.0% |
Equivalent Drug Dose | 1.25 µg/mm² |
Nominal Pressure | 9 atm (Refer IFU) |
Rated Burst Pressure | Rated Burst Pressure: 14/16 atm* (*RBP 14 atm for all diameter with length >40mm. (Refer IFU for more details)) |
Balloon Overhang | ≤ 0.5 mm |
Shaft Outer Diameter | Proximal: 2.13 F, Distal: 2.7 F (Refer IFU for more details) |
Usable Catheter Length | 142 cm (Refer IFU for more details) |
Guide Catheter Compatibility | 5F (Min. I. D. 0.056" / 1.42 mm) |
Max. Guidewire | 0.014" (0.36) |
Stent Diameter 2.00 mm | 0.83mm/0.033" |
Stent Diameter 2.25 mm | 0.85mm/0.033" |
Stent Diameter 2.50 mm | 0.91mm/0.036" |
Stent Diameter 2.75 mm | 0.98mm/0.039" |
Stent Diameter 3.00 mm | 0.99mm/0.039" |
Stent Diameter 3.50 mm | 1.06mm/0.042" |
Stent Diameter 4.00 mm | 1.16mm/0.046" |
Stent Diameter 4.50 mm | 1.19mm/0.047" |
Tip Entry Profile | 0.016" |
Elongated distal tip | 7.00 ± 0.5 mm |
Drug
Sirolimus
Polymer
Biodegradable & Biocompatible (PLLA + PLGA)
Delivery System
Rapid Exchange
Radiopaque Markers
Two Platinum / Iridium Markers
Crossing Profile
Crossing Profile
Primary Material
Cobalt Chromium (L605)
Anatomical Wizard
Clinical Sizing Precision
A tapered coronary stent system that adapts to vessel anatomy with different proximal and distal diameters. Features sirolimus drug eluting technology with biodegradable polymer coating for optimal vessel healing.
The BioMime MORPH's tapered design allows for optimized adaptation to the natural vessel morphology, ensuring complete lesion coverage and reducing the risk of geographic miss, particularly in vessels with significant diameter variation.
The Cobalt Chromium (L605) material provides optimal radial strength with a low strut thickness of 65μm, enhancing deliverability and conformability. The biodegradable polymer (PLLA + PLGA) ensures controlled Sirolimus drug release, minimizing long-term inflammation and promoting vascular healing. The material/polymer composition provides biocompatibility and mechanical integrity.
The BioMime MORPH's rapid exchange delivery system with a low crossing profile (0.83mm-1.19mm, depending on stent diameter) and highly flexible distal tip (0.016" tip entry profile, 7.00 ± 0.5 mm elongated distal tip) facilitates smooth navigation through complex lesions and precise stent placement. The balloon overhang of ≤ 0.5 mm contributes to accurate positioning and reduces the risk of edge dissection.
This product is manufactured by Meril Life Sciences and is distributed by Agile Healthcare across all districts of Telangana.
Yes, all Meril Life Sciences products distributed by Agile Healthcare, including the BioMime MORPH Sirolimus Eluting Tapered Coronary Stent System, strictly adhere to CDSCO guidelines and ISO 13485:2016 quality standards.
The BioMime MORPH Sirolimus Eluting Tapered Coronary Stent System is constructed using Cobalt Chromium (L605), ensuring high biocompatibility and durability.
Evermine50 Everolimus-Eluting Coronary Stent System
Drug Eluting Stents
BioMime Aura Sirolimus Eluting Coronary Stent System
Drug Eluting Stents
Proficient Sirolimus-Eluting Coronary Stent System
Drug Eluting Stents
Evermine50 Drug-Eluting Stent
Drug Eluting Stents